|Year : 2012 | Volume
| Issue : 3 | Page : 289-294
Retinopathy of prematurity: A study of prevalence and risk factors
Abdel H. A. A. Hakeem1, Gamal B Mohamed1, Mohamed F Othman2
1 Department of Pediatrics, Faculty of Medicine, Al Minia University, Egypt
2 Department of Ophthalmology, Faculty of Medicine, Al Minia University, Egypt
|Date of Web Publication||3-Jul-2012|
Abdel H. A. A. Hakeem
Department of Pediatrics, Faculty of Medicine, Al Minia University
Source of Support: None, Conflict of Interest: None
| Abstract|| |
Background: Retinopathy of prematurity (ROP) is a serious complication of prematurity treatment and can lead to blindness unless recognized and treated early.
Objective: The objective was to estimate the prevalence of ROP in preterm infants in the Neonatal Intensive Care Unit (NICU), to identify the risk factors which predispose to ROP, and to assess the outcome of these cases.
Materials and Methods: A ROP prospective screening survey was performed enrolling all prematures admitted to the NICU from January 2009 to December 2010, with a gestational age of 32 weeks or less at birth and a birth weight of 1500 g or less. Infants whose gestational age was >32 weeks or birth weight was >1500 g were included if they were exposed to oxygen therapy for more than 7 days. A total of 172 infants (84 males and 88 females) had retinal evaluation by indirect ophthalmoscopy from the fourth postnatal week and followed up periodically. Perinatal risk factors for ROP were assessed using univariate and multivariate analysis. Infants who progressed to stage 3 ROP were given laser therapy.
Results: Out of the studied 172 infants, 33 infants (19.2%) developed ROP in one or both eyes; 18 (54.5%) cases stage 1, 9 (27.3%) cases stage 2, and 6 (18.2%) cases stage 3. None of the studied neonates presented ROP at stages 4 or 5. The six cases diagnosed as ROP stage 3 underwent laser ablative therapy. Univariate analysis showed that there was a significant relationship between the occurrence of ROP and gestational age (P = 0.000), sepsis (P = 0.004), oxygen therapy (P = 0.018), and frequency of blood transfusions (P = 0.030). However, an insignificant relationship was found between the occurrence of ROP and sex, mode of delivery, birth weight, respiratory distress syndrome, patent ductus arteriosus, intraventricular hemorrhage, hypotension, phototherapy, duration of oxygen therapy, mechanical ventilation, and CPAP (all P > 0.05). Gestational age, sepsis, oxygen therapy, and frequency of blood transfusions remained significant variables after logistic regression analysis.
Conclusion: The prevalence of ROP in this study was 19.2%; low gestational age, sepsis, oxygen therapy, and frequent blood transfusions were significant risk factors for ROP. Laser was effective in treatment and decreasing the progression of ROP. As this is a unit-based study, a comprehensive countrywide survey on ROP in Egypt is recommended to determine any regional differences in disease prevalence.
Keywords: Oxygen Therapy, Prematurity, Risk Factors, Retinopathy of Prematurity
|How to cite this article:|
Hakeem AH, Mohamed GB, Othman MF. Retinopathy of prematurity: A study of prevalence and risk factors. Middle East Afr J Ophthalmol 2012;19:289-94
|How to cite this URL:|
Hakeem AH, Mohamed GB, Othman MF. Retinopathy of prematurity: A study of prevalence and risk factors. Middle East Afr J Ophthalmol [serial online] 2012 [cited 2021 Oct 26];19:289-94. Available from: http://www.meajo.org/text.asp?2012/19/3/289/97927
| Introduction|| |
Retinopathy of prematurity (ROP) is an important cause of preventable blindness in children.  In the Royal Blind School of Edinburgh, it accounts for up to 10% of childhood blindness,  and it is believed to account for 6-18% of childhood blindness in developed countries.  Recent advances in neonatal care in the last decade, have improved the survival rates for premature infants.  Consequently, the incidence of ROP has increased in parallel. ROP is under constant epidemiological study around the world. 
Early identification of retinal damage and the institution of appropriate treatment prevent blindness and offer child better overall development. 
ROP is characterized by abnormal neovascular development in the retina of premature infants. These abnormal blood vessels are fragile and can leak or bleed, scarring the retina and pulling it out of position. This causes a tractional retinal detachment, which is the main cause of visual impairment and blindness in ROP. 
The stages of ROP describe the ophthalmoscopic findings at the junction between the vascularized and avascular retina; stage 1 is a faint demarcation line, stage 2 is an elevated ridge, stage 3 is an extraretinal fibrovascular tissue, stage 4 is a subtotal retinal detachment, while stage 5 is a total retinal detachment. In addition, Plus disease, which indicates significant vascular dilation and tortuosity observed at the posterior retinal vessels, may be present at any stage and reflects the increased blood flow through the retina. 
In 1942, Terry  first described retrolental fibroplasia with implication of oxygen therapy as the causative agent. However, reports have found ROP in cases without oxygen therapy and even after oxygen therapy, not all premature infants develop ROP.  Three factors have shown consistent and significant association with ROP: low gestational age, low birth weight and prolonged exposure to supplementary oxygen following delivery. 
Other putative risk factors include mechanical ventilation,  sepsis,  intraventricular hemorrhage,  surfactant therapy,  anemia,  frequent blood transfusions,  and apnea.  The precise roles of these factors individually in the progression of the disease have not yet been determined. 
The aim of this prospective study was to estimate the prevalence of ROP in preterm infants at the Neonatal Intensive Care Unit (NICU) of Al-Minya University Hospital, to identify the risk factors which predispose to ROP, and to assess the outcome of these cases.
| Materials and Methods|| |
This prospective study was conducted in NICU of Al-Minya University Hospital in cooperation between the Departments of Neonatology and Ophthalmology. The study population included 172 neonates; all preterm infants admitted to the NICU from January 2009 to December 2010, with a gestational age of 32 weeks or less at birth and a birth weight of 1500 g or less. Infants whom gestational age was >32 weeks or birth weight was >1500 g were included if they were exposed to oxygen therapy for more than 7 days.  Also infants who were born between 32 and 34 weeks gestational age were examined if they had a course of instability (like sepsis, asphyxia or ventilation). Neonates who died before the first ophthalmologic examination were excluded. Infants with congenital anomalies, chromosomal abnormalities, inborn errors of metabolism were excluded from the study. All neonates included in this study were subjected to the following:
History: Perinatal history; detect risk factors as prematurity, sepsis (offensive liquor, premature rupture of membrane >18 hours, maternal urinary tract infection, and intrapartum fever> 38°C), and perinatal asphyxia.
Present history; includes the most common symptoms of respiratory distress requiring therapy oxygen, sepsis, phototherapy, congenital heart disease, and blood transfusion.
Weight, length, skull circumference, gestational age using new Ballard score, vital signs, neonatal reflexes, neurological manifestations, respiratory manifestations, and circulatory manifestations.
Local eye examination
All infants were examined regularly by the ophthalmologist at 1-2 weeks intervals from the 4 th postnatal week onwards. The eyes were dilated with a combination of cyclopentolate 0.1% and phenylephrine 0.1% eye drops applied one hour before the examination.
Indirect ophthalmoscopy with a 28 diopter lens was performed with speculum and scleral depression. Retinal examination by the ophthalmologist with retinal drawing and RetCam 2 fundus imaging was done when indicated.
ROP was defined as the incomplete or abnormal vascular proliferation of the retina, The ROP was classified by location on the retina (zone 1-3), and severity (stage 1-5), according to the criteria established by the International Committee for Classification of ROP.  All patients diagnosed with stage 3 ROP were treated with laser photocoagulation.
The ophthalmological examinations were initiated at the 4 th week of life and were repeated weekly or biweekly, using the schedule for follow-up recommended by AAP, AAO, and AAPO,  until full vascularization of the retina reached zone 3 (the most peripheral temporal retinal zone), or until full remission of ROP after treatment. In this study we examined a series of suspected pre- and postnatal risk factors for ROP to identify independent risk factors associated with the development of mild and severe forms of this disease in our NICU conditions. The prenatal variables were gestational age, birth weight, sex, and mode of delivery. The post-natal variables, were respiratory distress syndrome, oxygen therapy, phototherapy for jaundice, frequency of blood transfusions, sepsis (by clinical diagnosis, with either C-reactive protein greater than 6.0 mg/dl, or blood culture positive cases), hypotension (as identified by the standard mean for age and weight), intraventricular hemorrhage (as identified by cranial ultrasound), and patent ductus arteriosus (as identified by echocardiography).
Our study was carried out after approval by the ethical committee of the university. Informed consents were obtained from the parents of the subjects.
Data were analyzed by the Statistical Package for the Social Sciences (SPSS for windows, version 13.0). Descriptive statistics included the mean and standard deviation for numerical variables, and the percentage of different categories for categorical variables. The prevalence rate of ROP was described in simple proportion. Group comparisons were done by the Chi-squared (χ²) test or Fisher's exact test for categorical variables. A logistic regression model was performed and the adjusted OR (95% CI) was obtained for the risk factors which had been shown to be significant in the univariate analysis. A probability (P) of less than 0.05 was considered significant.
| Results|| |
The study population included 172 neonates; all preterms with a gestational age of 32 weeks or less at birth and a birth weight of 1500 g or less. This study also included infants whose gestational age was >32 weeks or birth weight was >1500 g with unstable condition during the duration from January 2009 to December 2010.
Out of the 172 neonates; 84 (48.8%) were males and 88 (51.2%) were females. The mean gestational age was 33.02 ± 1.72 weeks; 24 were ≤ 32 weeks; and 148 were >32 weeks. The birth weight ranged from 940 to 2010 g with a mean of 1510 ± 245 g. Seventy-two cases (41.9%) were delivered vaginally and 100 (58.1%) cases were delivered by cesarean section [Table 1].
Out of the 172 neonates; 33 (19.2%) cases developed ROP in one or both eyes classified as 18 (54.5%) cases stage 1, 9 (27.3%) cases stage 2, and 6 (18.2%) cases stage 3. None of the studied neonates presented ROP at stages 4 or 5.
[Table 2] shows the relationship between ROP and risk factors. There was a significant relationship between the occurrence of ROP and gestational age (P = 0.000), sepsis (P = 0.004), oxygen therapy (P = 0.018), and frequency of blood transfusions (P = 0.030). On the other hand, there was no significant relationship between the occurrence of ROP and sex, mode of delivery, birth weight, respiratory distress syndrome, patent ductus arteriosus, intraventricular hemorrhage, hypotension, phototherapy, and duration of oxygen therapy, mechanical ventilation, and CPAP (all P > 0.05).
|Table 2: Relationship between retinopathy of prematurity and risk factors|
Click here to view
[Table 3] shows the relationship between gestational age and stages of ROP. There was no significant relationship between the gestational age and stages of ROP (P = 0.325).
|Table 3: Relationship between gestational age and stages of retinopathy of prematurity|
Click here to view
[Table 4] shows the relationship between oxygen therapy and stages of ROP.
Those variables that were statistically significant after univariate analysis were analyzed using logistic regression analysis. Gestational age, sepsis, oxygen therapy, and frequency of blood transfusions remained significant variables [Table 5].
[Table 6] shows the outcome of ROP in studied cases. Intervention with laser was necessary for the six cases diagnosed as stage 3, and patients showed improvement on follow-up. The other 27 cases regressed spontaneously without intervention.
| Discussion|| |
Retinopathy of prematurity is a disorder of retinal vascular development in preterm infants. It continues to be a significant complication in preterm neonates despite advances in neonatal care and remains a major cause of childhood blindness worldwide. 
The prevalence of ROP in this study was 19.2% and this was less than that reported in many other studies; 24% in India,  29.2% in Singapore,  and 32.4% in Pakistan.  This can be explained by the fact that these studies involved only very low birth weight infants. However, it is higher than the study done in Beijing which involved infants with higher gestational age and birth weight (up to 2 kg and /or 34 weeks gestational age) and reported a prevalence of 10.8%. 
ROP is a multifactorial disease involving many factors. Low-gestational age, low-birth weight, sepsis, oxygen therapy, respiratory distress syndrome, and blood transfusion have been suspected to influence the incidence of ROP.  The most significant risk factors for development of ROP were low-gestational age and low-birth weight, as shown in many studies. ,, In our study, low-gestational age, sepsis, oxygen therapy, and frequency of blood transfusions were found to be risk factors for development of ROP independently. Meanwhile, sex, mode of delivery, birth weight, respiratory distress syndrome, patent ductus arteriosus, intraventricular hemorrhage, hypotension, phototherapy, duration of oxygen therapy, mechanical ventilation, and CPAP were nonsignificant risk factors by using univariate analysis.
As regard the effect of low-gestational age on occurrence of ROP, we found it the most important risk factor in ROP. This was in agreement with the results of studies done by Shah et al.,  Karna et al.,  and Fortes et al.  This was explained by immaturity of vascularization that induces an increased susceptibility of the retina to oxidative damage and to a number of perinatal factors which include hyper and hypoxia, blood transfusions, and sepsis. We found nonsignificant relationship between gestational age and the severity of ROP, but this was in disagreement with other studies, , showing that lower gestational age was significantly associated with severe ROP.
We found that birth was an insignificant factor for the development of ROP which concurs with Arroe and Peitersen.  We found that birth weight was insignificant factor for development of ROP. But this was in disagreement with many studies ,, which reported that lower birth weight was significantly associated with development of ROP, and explained that by more susceptibility for oxygen therapy, prolonged ventilation, sepsis, and blood transfusion in very low birth weight infants. In this work this may be related to the small number of patients (3 out of 172 cases) whose birth weight was less than 1000 g.
In this study, we found that sepsis was significantly associated with the development of ROP. This was in agreement with Shah et al.,  and Vinekar et al.,  which may be due to the effect of endotoxins on retinal blood vessels. On the other hand, this was in disagreement with the results of Chaudhari et al.,  and Smith. 
Oxygen therapy was an independent risk factor for the development of ROP. ,, We found a significant relationship between the occurrence of ROP and use of oxygen therapy, but there was no significant relationship between oxygen therapy and stages of ROP. On the other hand, Palmer et al.,  reported that oxygen therapy was a nonsignificant factor for occurrence of ROP. They reported that ROP may develop in cases that did not receive oxygen therapy.
Some studies reported that a duration of oxygen therapy more than 7 days was a significant risk factor for development of ROP. , Meanwhile, in our study we found it insignificant which was in agreement with the results of Dutta et al.  We found that mechanical ventilation and CPAP were nonsignificant risk factors for ROP and this agreed with Murthy et al.  However, others observed that ventilatory support and CPAP were significantly associated with development of ROP. ,
In our study, we found that the frequency of blood transfusions is an independent risk factor for development of ROP, and this agreed with Deepak et al.  This can be explained by the fact that, adult RBCs are rich in 2, 3 DPG and adult hemoglobin which binds less firmly to oxygen, thus releasing excess oxygen to the retinal tissue. While Hirano et al.,  stated that it is controversial and iron overload rather than number of transfusions may contribute to the development of ROP.
Our study revealed insignificant relationship between sex and occurrence of ROP, in contrast to Darlow et al.,  who found that male sex is a significant risk factor. In agreement with Seiberth and Lindarkomp,  we found insignificant relationship between the mode of delivery and occurrence of ROP. But this was in disagreement with Shah et al.,  who found that cesarean section delivery was significantly associated with occurrence of ROP.
Other risk factors including respiratory distress syndrome, patent ductus arteriosus, intraventricular hemorrhage, hypotension, and phototherapy showed insignificant relationship with the occurrence of ROP. Similarly Taqui et al.,  reported insignificant relation between ROP and patent ductus arteriosus and intraventricular hemorrhage, but observed a significant relation between respiratory distress syndrome and the development of ROP and related this to the fact that systemic hypoxia results in retinal hypoxia and more need for oxygen therapy. On the other hand, Shah et al.,  reported a significant relation between ROP development and patent ductus arteriosus, intraventricular hemorrhage, and hypotension. Chaudhari et al.  observed a insignificant effect of phototherapy on ROP.
In multivariate analysis after logistic regression analysis, it was confirmed that low gestational age, sepsis, oxygen therapy, and frequency of blood transfusions were significant risk factors for development of ROP.
Laser photocoagulation was found to be very effective in regressing ROP. In agreement with Coats et al.,  we found that the six cases that required laser intervention improved and ROP regressed with regular follow-up. Laser is now the preferred mode since the most severe forms of the disease are more easily treated with laser than with cryotherapy. 
| Conclusion|| |
We are aware that a limitation of this study is the small number of patients. In conclusion, the prevalence of ROP in this study was 19.2%, the data of this study suggest that low gestational age, sepsis, oxygen therapy, and frequency of blood transfusions are independent risk factors in the development of ROP. Clinicians should be aware of the presence of the additional risk factors when monitoring preterm infants. The analysis of risk factors for ROP development will help to understand and predict it in severe preterm infants. The timely retinal screening of high-risk preterm infants is important to prevent the development of advanced ROP. Since ROP may produce serious sequelae up to complete blindness, all efforts must be made to prevent the development of advanced ROP through elimination of preterm births, changes in the neonatal care, and improvement in detection of threatening ROP markers.
| Acknowledgments|| |
Our appreciation to all the members of NICU at Minia University Pediatric Hospital, Ophthalmology Department and also the parents of the newborn for their patience and compliance.
| References|| |
|1.||Coats DK, Aaron MM, Mohamed AH. Involution of retinopathy of prematurity after laser treatment: Factors associated with development of retinal detachment. Am J Ophthalmol 2005;140:214-22. |
|2.||Fleck BW, Dangata Y. Causes of visual handicap in the Royal Blind School, Edinburgh, 1991-2. Br J Ophthalmol 1994;78:421. |
|3.||Dominico R, Davis K, Davis O. Documenting the NICU design dilemma: Comparative patient progress in open-ward and single family room units. J Perinatol 2011;31:281-8. |
|4.||Akçakaya A, Yaylali S, Akçay G. Screening for retinopathy of prematurity in a tertiary hospital in istanbul: Incidence and risk factors. J Pediatr Ophthalmol Strabismus 2011;15:1-5. |
|5.||Fanaroff AA, Martin RJ, editors. Neonatal perinatal medicine. 7 th ed. Louis: Mosby; 2002. p. 676-745. |
|6.||Azad R, Chandra P. Retinopathy of prematurity. J Indian Med Assoc 2005;103:370-2. |
|7.||International Committee for the Classification of Retinopathy of Prematurity. The International Classification of Retinopathy of Prematurity revisited. Arch Ophthalmol 2005;123:991-9. |
|8.||Terry TL. Extreme prematurity and fibroblastic overgrowth of persistent vascular sheath behind each crystalline lens. Am J Ophthalmol 1942;25:203-4. |
|9.||Chawla D, Agarwal R, Deorari A. Retinopathy of prematurity. Indian J Pediatr Paul VK. Indian J Pediatr. 2008;75:73-6. |
|10.||Kim T, Sohn J, Yoon YH. Postnatal risk factors of retinopathy of prematurity. Paediatr Perinat Epidemiol 2004;18:130-4. |
|11.||Shah VA, Yeo CL, Ling YL. Incidence, risk factors of retinopathy of prematurity among very low birth weight infants in Singapore. Ann Acad Med Singapore 2005;34:169-78. |
|12.||Gupta VP, Dhaliwal U, Sharma R. Retinopathy of prematurity-risk factors. Indian J Pediatr 2004;71:887-92. |
|13.||Karna P, Muttineni J, Angell L. Retinopathy of prematurity and risk factors: A prospective cohort study. BMC Pediatr 2005;5:18. |
|14.||Englert A, Saunders A, Purohit D. The effect of anemia on retinopathy of prematurity in extremely low birth weight infants. J Perinatol 2001;21:21-6. |
|15.||Imren A, Sibel O, Gursel Y. Risk Factors in the development of mild and severe retinopathy of prematurity. J AAPOS 2006;10:449-53. |
|16.||American Academy of Pediatrics Section on Ophthalmology; American Academy of Ophthalmology; American Association for Pediatric Ophthalmology and Strabismus. Screening examination of premature infants for retinopathy of prematurity. Pediatr 2006;117:572-6. |
|17.||Murthy KR, Nagendra BK. Analysis of risk factors for the development of ROP in preterm infants at a tertiary referral hospital in South India. Acta Medica Lituanica 2006;13:147-51. |
|18.||Taqui AM, Syed R, Chadry TA. Retinopathy of prematurity: Frequency and risk factors in a tertiary care hospital in Karachi, Pakistan. J Pak Med Assoc 2008;58:186-90. |
|19.||Chen Y, Li X-x, Yin H, Gilbert C, Liang JH, Jiang YR, et al. Risk factors for retinopathy of prematurity in six neonatal intensive care units in Beijing, China. Br J Ophthalmol 2008;92:326-30. |
|20.||Fortes JB, Barros CK, Lermann VL. Prevention of blindness due to retinopathy of prematurity at hospital de clinicas de porto alegre, Brazil: Incidence, risk factors, laser treatment and outcomes from 2002 to 2006. Acta medica Lituanica 2006;13:130-6. |
|21.||Dammann O, Brinkhaus MJ, Bartels DB. Immaturity, perinatal inflammation, and retinopathy of prematurity: A multi-hit hypothesis. Early Hum Dev 2009;1016:1-5. |
|22.||Fortes JB, Eckert GU, Procianoy L. Incidence and risk factors for retinopathy of prematurity in very low and in extremely low birth weight infants in a unit-based approach in southern Brazil. Eye (Lond) 2009;23:25-30. |
|23.||Arroe M, Peitersen B. Retinopathy of prematurity: Review of a seven year period in a Danish neonatal intensive care unit. Acta Paediatr 1994;83:501-5. |
|24.||Roberto F, Miguel AH, Ricardo JH. Screening for retinopathy of prematurity: Results of a 7-year Study of underweight newborns. Arch Med Res 2007;38:440-3. |
|25.||Vinekar A, Dogra M, Sangtam T. Retinopathy of prematurity in Asian Indian babies weighting greater than 1250 gram at birth; ten years data from tertiary care center in a developing country. Indian J Ophthalmol 2007;55:331-6. |
|26.||Chaudhari S, Patwardhan V, Vaidya U. Retinopathy of prematurity in a tertiary care center, incidence, risk factors and outcomes. Indian Pediatr 2009;46:219-24. |
|27.||Smith LE. Pathogenesis of retinopathy of prematurity. Acta Paediatr Suppl 2002;91:26-8. |
|28.||Weinberger B, Laskin DL, Heck DE. Oxygen toxicity in premature infants. Toxicol Appl Pharmacol 2002;181:60-7. |
|29.||Palmer AE, Hardy RJ, Dobson V; Cryotherapy for Retinopathy of Prematurity Cooperative Group. Outcomes following Threshold Retinopathy of Prematurity. Final results from the multicenter trial of cryotherapy for retinopathy of prematurity. Arch Ophthalmol 2005;123:311-8. |
|30.||Ikeda H, Kuriyama S. Risk factors for retinopathy of prematurity requiring photocoagulation. Jpn J Ophthalmol 2004;48:68-71. |
|31.||Dutta S, Alaraop S, Narang A. Risk factors of threshold retinopathy of prematurity. Indian Pediatr 2004;41:665-71. |
|32.||Deepak C, Ramesh A, Ashok KD. Retinopathy of prematurity. Indian J Pediatr 2008;75:73-6. |
|33.||Hirano K, Morinobu T, Kirn H. Blood transfusion increases radical promoting non-transferrin bound iron in preterm infants. Arch Dis Child Fetal Neonatal Ed 2001;84:188-93. |
|34.||Darlow A, Hutchinson JL, Henderson S. Prenatal risk factors for severe retinopathy of prematurity among very preterm infants of the Australian and New Zealand Neonatal Network. Pediatrics 2005;115:990-6. |
|35.||Seiberth V, Lindarkomp O. Risk factors in retinopathy of prematurity: A multivariate statistical analysis. Ophthalmologica 2000;214:131-5. |
|36.||Cordelia C, Alistair F, Edmund A. Management of retinopathy of prematurity. Current Paediatr 2005;15:99-105. |
[Table 1], [Table 2], [Table 3], [Table 4], [Table 5], [Table 6]
|This article has been cited by|
||Efficacy and safety of CPAP in low- and middle-income countries
| ||A Thukral,M J Sankar,A Chandrasekaran,R Agarwal,V K Paul |
| ||Journal of Perinatology. 2016; 36: S21 |
|[Pubmed] | [DOI]|
||Evidence to modify guidelines for routine retinopathy of prematurity screening to avoid childhood blindness in middle-income countries
| ||Miroslava Paolah Meraz-Gutiérrez,Francisco Javier Olguín-Manríquez,Andrea Elizabeth Arriola-López,David Berrones-Medina,Kenneth W. Price,Virgilio Morales-Canton,María Ana Martínez-Castellanos |
| ||Revista Mexicana de Oftalmología. 2016; |
|[Pubmed] | [DOI]|
| ||Mahuya Pal Chattopadhyay,Ashish Pradhan,Ritesh Singh,Sudip Datta,Poonam Marwah,Deepak Chawla,Jagdish Chander,Vishal Guglani,Ashish Marwah |
| ||Indian Pediatrics. 2015; 52(2): 157 |
|[Pubmed] | [DOI]|
||Comparison of Digital Imaging Screening and Indirect Ophthalmoscopy for Retinopathy of Prematurity
| ||Zahraa Mohamed Ezz El Din,Mohamed Ahmed El Sada,Aliaa Adel Ali,Khalid Al Husseiny,Aly Abdel Rahman Yousef |
| ||The Indian Journal of Pediatrics. 2015; 82(1): 80 |
|[Pubmed] | [DOI]|
||Retinopathy of Prematurity in Port Harcourt, Nigeria
| ||Adedayo O. Adio,Rosemary O. Ugwu,Chidi G. Nwokocha,Augusta U. Eneh |
| ||ISRN Ophthalmology. 2014; 2014: 1 |
|[Pubmed] | [DOI]|
||670nm Photobiomodulation as a Novel Protection against Retinopathy of Prematurity: Evidence from Oxygen Induced Retinopathy Models
| ||Natoli, R. and Valter, K. and Barbosa, M. and Dahlstrom, J. and Rutar, M. and Kent, A. and Provis, J. |
| ||PLoS ONE. 2013; 8(8) |
||Screening ROP ve fn Ostrava | [Screening ROP in the University Hospital Ostrava]
| ||Timkovič J., Němčanský J, Cholevík D, Pokrývková M, Poláčková R |
| ||Ceska a Slovenska Oftalmologie. 2013; 69(2): 51-57 |
||Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010
| ||Hannah Blencowe,Joy E. Lawn,Thomas Vazquez,Alistair Fielder,Clare Gilbert |
| ||Pediatric Research. 2013; 74: 35 |
|[Pubmed] | [DOI]|
||Retinopathy of prematurity: Incidence, risk factors, and outcome
| ||Sabzehei MK, Afjeh SA, Farahani AD, Shamshiri AR, Esmaili F |
| ||Archives of Iranian Medicine. 2013; 16(9): 507-512 |
||Outcomes of binocular indirect ophthalmoscope photocoagulation for retinopathy of prematurity
| ||Zhou Y, Yizuo H, Su Y, Chen C, Xing Y |
| ||Medical Journal of Wuhan University. 2013; 34(6): 905-908 |
||Delayed luminance and chromatic contrast sensitivity in infants with spontaneously regressed retinopathy of prematurity
| ||Rain G. Bosworth,Shira L. Robbins,David B. Granet,Karen R. Dobkins |
| ||Documenta Ophthalmologica. 2013; 127(1): 57 |
|[Pubmed] | [DOI]|